Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load
NCT02158221Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Jun 2014
- Primary completion
- Nov 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of pituitary adenylate cyclase-activating polypeptide in migraine without aura (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoint: Incidence of migraine attacks induced by PACAP at 12 hours. Started Jun 2014; status: completed.
02
Drugs
pituitary adenylate cyclase-activating polypeptide
03
Conditions
migraine without aura
Beyond the preview
Go deeper on NCT02158221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02158221.